Iowa State Board of Regents Dormitory Revenue Bonds Rated 'A' Jan 00

  • ID: 1814992
  • January 2000
  • Region: Iowa
  • Standard & Poors
1 of 2

CHICAGO (Standard & Poor's CreditWire) Jan. 14, 2000--Standard & Poor's today assigned its single-'A' rating to Iowa State Board of Regents' $9.53 million dormitory revenue bonds series 2000A due July 1, 2003-2027, issued for Iowa State University of Science and Technology. The bonds are scheduled to sell Jan. 19, 2000. In addition, Standard & Poor's affirmed its single-'A' rating on the university's outstanding dormitory revenue bonds and its single-'A'-plus rating on the university's outstanding unlimited-fee GO bonds. Credit factors include: ý-- The university's general credit strength and strong state support as a land-grant institution, ý-- The dormitory system's financial strength and diversity, ý-- Sound universitywide financial performance, ý-- Stable demand, and ý-- A moderate 5.6% debt burden. An offsetting credit...

Companies mentioned in this report are:

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.